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Abstract
Introduction: Particulate matter air pollution constitutes an important factor affecting the course of various respiratory and car-
diovascular diseases. Two main monitored groups of particulate pollution are particulate matter with the aerodynamic diameter 
below 10 μm (PM10) and 2.5 μm (PM2.5). One of the most important respiratory diseases is chronic obstructive pulmonary 
disease (COPD). Clinical presentation of COPD and cardiovascular diseases is similar and can cause complications during therapy. 
The study explores connection between particulate matter and COPD exacerbations in population with cardiovascular cause of 
symptoms excluded. 
Material and methods: Analysis was based on data from hospitalisations in the years 2006-2016 in the hospitals of Upper 
Silesian Agglomeration, Poland. The data were correlated with meteorological conditions and particulate matter concentrations 
up to 90 days before hospital admission. 
Results: During the whole observation period no connection between PM10 concentration changes and COPD exacerbations 
were observed. On the other hand PM 2,5 influence started to be significant on 14 day before admission (RR 1.06) and increased 
up to maximal analysed period of 90 days (RR 1.32). 
Conclusions: Overall this study highlights the importance of particulate matter pollution emission impact on COPD exacerbations 
in a long time perspective.
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Introduction
Available literature concentrates on the effect 
of air pollution on the prevalence of exacerbation 
episodes of respiratory and cardiovascular diseases. 
The evidence about exacerbation of respiratory 
diseases, including chronic obstructive pulmona-
ry disease (COPD) in the population of patients 
suffering from cardiovascular diseases, is scarce. 
Particular matter constitutes a mixture of 
chemical compounds, heterogenous in terms of 
composition and physical properties, differing 
depending on their source. The World Health 
Organisation (WHO) points to the increase of the 
incidence rate of adverse effects of exposure to 
PM along with the growth of the concentrations 
thereof. At the same time it is difficult to deter-
mine the minimum concentration below which 
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such effects do not occur [1]. In 2010, PM contri-
buted to over 3 million deaths, which constitutes 
an increase by 300 thousand in relation to 1990. 
PM is a significant factor exacerbating the course 
of respiratory and cardiovascular diseases [2]. Fur-
thermore, a growing body of evidence links PM to 
COPD development, which led to the inclusion of 
PM in a group of important factors contributing to 
COPD prevalence in the annual GOLD report [3].
In 2002, COPD was the fifth leading cause of 
death worldwide, and is projected to be the third 
by 2020 [4]. The natural course of the disease 
features exacerbation periods, which accelerate 
the drop in lung function tests values, contribute 
to the mortality rate increase, and significan-
tly elevate healthcare systems costs [4–5]. The 
main cause of exacerbation in COPD are viral 
and bacterial infections. Ambient pollution and 
meteorological factors are also considered among 
precipitating agents or cofactors [4]. It has been 
demonstrated that there is a  relation between 
exposure to PM and intensification of local in-
flammation in the area of the respiratory tract, as 
well as a systemic inflammatory response in con-
sequence of changes in phagocytosis, production 
of chemotactic compounds, cytokines and oxygen 
free radicals [6]. It has been proven that there is 
a relation between exposure to PM, the drop of 
spirometric values [7–8], increase of dyspnoea, 
wheezes in patients with asthma and COPD [9]. 
It entailed higher consumption of inhalation me-
dications applied in the treatment of COPD [10] 
and a bigger number of hospitalisations due to 
COPD exacerbation [11–13]. Simultaneously, 
the fundamental symptom of the COPD exacer-
bation — intensified dyspnoea above the normal 
variability — occurs in the course of exacerbation 
of congestive heart failure (CHF) and other car-
diovascular diseases. CHF patients can present 
obstructive ventilation disorders too, which may 
be suggestive of the comorbidity or presence of 
COPD. Owing to similar risk factors (smoking), 
the population of cardiovascular patients consti-
tutes a group predisposed to the development of 
COPD. A similar clinical picture, as well as the 
frequent comorbidity of cardiovascular diseases 
and COPD, account for the diagnostic and the-
rapeutic challenge in the event of exacerbation. 
Moreover, it introduces potential bias in studies 
analysing PM concentrations and natural course 
of those diseases [14]. 
This study analyses the effect of PM with 
the aerodynamic diameter below 10 μm (PM10) 
and 2.5 μm (PM2.5) on COPD exacerbation in the 
population of cardiovascular patients depending 
on the exposure time. In order to avoid an erro-
neous classification of patients symptoms, car-
diovascular database was employed. The aim of 
the study was the selection of patients with stable 
cardiovascular disease and concomitant COPD 
exacerbation, thus excluding the possibility of 
misdiagnosing the source of patients complaints.
Material and methods 
The Silesian Cardiovascular Database (Ślą-
ska Baza Sercowo-Naczyniowa) served as a so-
urce of data concerning hospitalisations due to 
COPD exacerbation. This database is administe-
red by the Science Department of Silesian Centre 
of Heart Disease in Zabrze and the Department 
of Biostatistics of the Medical University of 
Silesia in Katowice under an agreement signed 
with the Silesian Provincial Department of the 
Polish National Health Fund. It contains infor-
mation relating to hospitalisations in the wards 
of cardiology, cardiac surgery, vascular surgery, 
diabetology, internal medicine, and intensive 
care units with diagnosed conditions classified 
as cardiovascular diseases (coded as I01-I99 
according to the International Classification 
of Diseases ICD-10). It covers hospitalisations 
in the years 2006–2016 in 310 hospitals. The 
inclusion criterion for patients was COPD exa-
cerbation defined as the primary hospitalisation 
diagnosis coded as J44 according to ICD-10. 
Cardiovascular diseases were ruled out as the 
cause of symptoms reported by the patient. It 
corresponded to 12,889 hospitalisations, whose 
data are included in the database. 
The data relating to particular matter pol-
lution, i.e. PM2.5 and PM10, were obtained 
from the Upper Silesian air quality monitoring 
system database available for the public on the 
website of the Silesian Regional Inspectorate of 
Environment. Furthermore, this register provided 
information on meteorological conditions — am-
bient temperature, humidity, wind velocity, at-
mospheric pressure. The analysis covered figures 
relating to air monitoring stations located in Dą-
browa Górnicza, Gliwice, Katowice, Sosnowiec, 
Tychy, and Zabrze, adequately to the analysed 
population of the Upper Silesian Agglomeration. 
The Upper Silesian Agglomeration is a part of 
Silesian Voivodeship which constitutes 4% of 
Poland surface with 18.1% of industrial factories. 
Regional industry emits 23% of the whole country 
particulate air pollution.
Statistical analysis was performed using the 
generalised linear model with the logarithmic link 
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Table 1. The most frequent cardiovascular comorbidities 
No. ICD-10 Comorbidity Number of patients Percentage
1 I10 Essential (primary) hypertension 3461  26.85
2 I50.9 Heart failure, unspecified 1370  10.63
3 I25.9 Chronic ischaemic heart disease, unspecified 1334  10.35
4 I25.0 Atherosclerotic cardiovascular disease, so described 1038  8.05
5 I48 Atrial fibrillation and flutter 906  7.03
6 I11.9 Hypertensive heart disease without (congestive) heart failure 901  6.99
7 I70.9 Generalised and unspecified atherosclerosis 863  6.7
8 I50.0 Congestive heart failure 644 5
9 I25.8 Other forms of chronic ischaemic heart disease 470  3.65
10 I25.5 Ischaemic cardiomyopathy 397  3.08
ICD-10: International Classification of Diseases 
Table 2. Mean, standard deviation (SD) and range of yearly concentrations of PM pollution 
Year PM10 [μg/m3] SD MIN MAX PM2.5 [μg/m3] SD MIN MAX
2006 50.16 45.89 8.67 385.75 unavailable – – –
2007 39.27 25.05 10.75 185.2 unavailable – – –
2008 40.07 23.15 10.75 169.75 unavailable – – –
2009 41.07 25.56 8.25 159.75 36.13 23.84 6 140.5
2010 53.19 41.08 7.33 254.6 45.92 42.96 6 313
2011 54.69 40.16 9.5 356.33 42.39 35.05 5 223
2012 52.81 48.33 9.8 410.17 40.75 46.07 5.5 358.5
2013 43.36 24.47 12.17 192.67 35.42 27.23 4. 205
2014 41.68 26.61 9.67 163/5 35.02 28.88 3.5 147.5
function. Besides the season of the year, the fol-
lowing meteorological parameters were assumed 
as interfering variables: ambient temperature, hu-
midity, wind velocity, atmospheric pressure. The 
Poisson distribution of the dependent variable 
was assumed. Measurements from the monitoring 
stations referring to the whole day were averaged 
for the Upper Silesian Agglomeration and analy-
sed in juxtaposition with the hospitalisation data 
for the basic diagnosis J44. The period of up to 
90 days before the day of hospital admission was 
considered. Statistical significance was assumed 
for p < 0.05. Relative risk was calculated for 
1 interquartile range increase in the pollutant 
concentration. 
The analysed population
From amongst hospitalisations subjected to 
the analysis, 61.82% were male patients, and 
38.18% were females. The average age as of the 
time of admission was 71 years with the standard 
deviation of 10 years. The whole population of 
the Upper Silesian Agglomeration is estimated at 
up to 3.5 million.
Cardiovascular comorbidities 
Besides the main diagnosis, hospitalisation 
reporting to the Polish National Health Fund con-
tains up to three diagnoses of comorbidities. Table 
1 provides information on 10 most frequent car-
diovascular diagnoses in the analysed population. 
Results 
PM concentrations in the analysed period 
PM10 measurements were available for the 
entire period analysed. Values of PM2.5 concentra-
tions were available from June 2009 until the end 
of the analysed period. The mean yearly concentra-
tions of PM pollution are collected in Table 2. The 
weekly concentrations of particulate pollutants 
for an exemplary year are presented in Figure 1.
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Figure 1. Plot of the weekly PM10 and PM2.5 densities over the year 2012
Impact of PM concentrations on COPD 
exacerbation 
No significant relationship between a change 
in the PM10 concentration up to the 90th day 
before hospitalisation and the risk of COPD exa-
cerbation was demonstrated in the analysed popu-
lation. A relation between a change in the PM2.5 
concentration and exacerbation was shown for 
the mean concentration for the period of over 14 
days before the date of admission. The relative risk 
value (RR) was calculated per 1 interquartile ran-
ge of pollutant concentration increase, equalling 
29.58 μg/m3 for PM10 and 25.00 μg/m3 for PM2.5.
Discussion and conclusions
To the best of our knowledge, this paper is 
the first to focus on analysis of effects of PM pol-
lutants on COPD exacerbation in patients with 
cardiovascular comorbidities. 
The results obtained point to a significant 
effect of an increase in the PM2.5 concentration, 
but not PM10 concentration, on COPD exacerba-
tion in the period of at least 2 weeks before the 
date of admission to hospital.
Standard concentrations of PM pollutants 
quoted by WHO, besides target values, provide 
also transitional ones. Mean annual levels in the 
analysed period did not go beyond 55 μg/m3 for 
PM10; for PM2.5 mean concentrations were below 
46 μg/m3. The values obtained by us point to re-
aching the second transitional value proposed by 
WHO in terms of PM10, and the first transitional 
value in terms of PM2.5. These levels correspond 
to the 9% and 15% increase, respectively, in the 
risk of long-term mortality rate compared to the 
target values [1]. International guidelines indicate 
a significant role of pollutants in the pathogenesis 
of cardiovascular and respiratory diseases, even 
in concentrations remaining below the actual air 
quality standards [15].
In a study covering the area of Beijing, where 
the observed concentrations of PM are ca. two or 
three times higher than in our study, an increase 
in the intensity of inflammation and a rise of the 
number of reported respiratory symptoms was 
observed. In contrast to our results, changes in 
the concentrations of PM2.5 and PM10 within 
the range of up to 7 days had a significant effect 
[16]. A 6-month-long observation from European 
research centres pointed to a  relationship be-
tween PM10 and respiratory symptoms. Similar 
connection for PM2.5 was not found. The authors 
emphasise a bigger role of PM10 in the toxicity 
of PM pollution. Nevertheless, whereas the de-
monstrated values of concentrations of PM10 
are comparable with the ones determined in our 
study, the observed concentrations of PM2.5 are 
significantly lower [17]. An analysis based on the 
population of Massachusetts, USA, where the ob-
served concentrations of PM pollutants fall within 
the range of target concentrations according to 
WHO, demonstrated the odds ratio (OR) of 0.94 at 
the 95% confidence interval (95%CI) 0.88–1.01 for 
COPD exacerbation with the exposure to PM2.5. 
This value took into account ambient tempera-
ture and reported infections of the respiratory 
tract as important confounders. The analysis 
covered a 3- week-long period, and considering 
the confidence interval given in the study, the 
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Table 3. Impact of PM pollution concentration increase on the risk of chronic obstructive pulmonary disease exacerbation 
requiring inpatient treatment. Statistically significant associations are shown in bold
PM10  PM2.5
Analysed period RR p RR p
At admission 1.02 0.11 1.00 0.79
last 3 days before admission 1.00 0.71 1.00 0.89
last 5 days before admission 0.99 0.70 1.01 0.71
last 7 days before admission 1.00 0.95 1.02 0.33
last 14 days before admission 1.01 0.50 1.06 < 0.05
last 30 days before admission 1.01 0.81 1.10 < 0.005
last 40 days before admission 0.99 0.79 1.14 < 0.0005
last 50 days before admission 1.01 0.79 1.21 < 0.0001
last 60 days before admission 1.01 0.81 1.24 < 0.0001
last 90 days before admission 1.00 0.85 1.32 < 0.0001
RR: relative risk; p: probability value 
obtained results also point to the lack of effect for 
a short exposure time, as demonstrated by us [18]. 
A  meta-analysis examining the relationship 
between air pollutants and hospital admissions 
due to COPD exacerbation revealed a marginal 
relationship (OR 1.01, 95%CI 1.0–1.01) for PM10. 
The influence of PM2.5 was likewise marginal, 
although expressed more profoundly (OR 1.03, 
95%CI 1.01–1.05). For the sake of comparison, 
the results obtained by us point to a much higher 
RR, in the time perspective of 90 days obtaining 
the value 1.32. The authors of the meta-analysis 
underline that the relationship between the con-
centration of PM2.5 and COPD exacerbation be-
comes more distinct for higher concentrations of 
PM2.5 [19]. De Vries et al. in their work empasise 
the significance of a delay in exerting the effect 
due to pollution and, consequently, of the need 
to choose an appropriate period for the analysis. 
For PM2.5, the strongest effect is marked when 
a mean value covering several preceding days is 
applied. It is justified by experimental studies 
pointing to a cumulative role of modification of 
elements of the immunological reaction, such as 
chemotaxis and phagocytosis [20]. Furthermore, 
when comparing data obtained in different stu-
dies, one needs to take into account the difference 
in the composition of PM pollution, resulting 
from different sources and secondary chemical 
reactions. A study contrasting the influence of 
PM10 in 29 European cities demonstrated signi-
ficant heterogeneity depending on the observed 
area [21]. Similar works pertaining to the effect 
of PM2.5 pointed to increased mortality related to 
PM2.5 generated by human activity, which is the 
main source of air pollution in the area covered 
by our study [22, 23]. 
The data obtained by us are based on infor-
mation from hospitalisation reporting. Therefo-
re, they disregard the effect of PM pollution on 
the cases of exacerbation which do not require 
hospitalisation, or patients who do not consent 
to the inpatient treatment. Studies focusing on 
the sales of respiratory medication demonstra-
ted a relationship between the concentration of 
PM10 and the sales of medications used in the 
treatment of asthma and COPD. The effect of PM 
manifested itself on the date of the drug purchase, 
as well as for a mean value for various lag periods. 
Nevertheless, the analysed population potential-
ly covered also patients with asthma and other 
respiratory diseases [24, 25]. Data pertaining to 
the increase in the number of outpatient consul-
tations resulting from the increased exposure to 
PM pollution are poorer than the data concerning 
hospitalisations. The study based on the observa-
tions in Beijing points to a very insignificant re-
lation, although it covers only one centre, which 
may result in an analysis of a non-representative 
sample [26]. An analogous research covering an 
industrialised territory of Taiwan demonstrated 
a positive correlation between PM2.5 and PM10 
concentrations on one hand and outpatient visits 
caused by COPD on the other [27]. The above 
mentioned studies indicate the possibility of 
underestimation of the effect of PM pollution on 
COPD exacerbation if only hospitalisations are 
taken into consideration. 
The statistical analysis took into account va-
riables relating to meteorological phenomena as 
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disturbing variables. It was demonstrated that an 
increase in the air temperature outside buildings 
is connected with a rise of respiratory symptoms, 
such as dyspnoea, coughing, and expectoration [28]. 
Temperature increase by 1ºC entails an increase 
of the incidence of COPD exacerbation estimated 
at the level of 2.7–5.4%, depending on the study. 
In one of the studies, it translated into an incre-
ase of emergency admissions to hospital [29, 30]. 
Other meteorological factors were subjected to 
a  less comprehensive analysis. A  correlation 
between the number of outpatient consultations 
due to COPD and the atmospheric pressure, wind 
velocity, humidity, and insolation was presented, 
although it proved impossible to demonstrate this 
relationship for some parts of the analysed area 
[31, 32]. Furthermore, meteorological variables 
influence the concentration of PM pollution af-
fecting a lag between concentration change and 
clinical manifestation [33].
In our study, we assumed a mean value of 
pollutants concentrations as the exposure me-
asure. Depending on the amount of time spent 
inside buildings, the use of air conditioning or 
even a small change in environment, these valu-
es might not correspond to the actual exposure 
of a specific individual [34, 35]. The exposition 
differences and subsequent clinical changes were 
demonstrated for two locations with various 
characteristic in London [36]. Similar differences 
were proven for coastal regions and areas without 
contact with seashore [37].
Basing the analysis on the cardiovascular 
diseases database allowed to limit the risk of 
inappropriate classification of the source of health 
issues of the patient. At the same time, it led to 
the analysis being performed on a selected popu-
lation with different characteristics than those of 
the general population. Several causes of hospi-
talisation cannot be ruled out, either. Regrettably, 
the data reporting system used by the National 
Health Fund does not contain information on 
present smoking status. A number of studies 
suggest different pollutants impact depending on 
the actual smoking habit [38].
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